Sierra Leone President, Julius Maada Bio, has called for stronger regional cooperation and international support to tackle insecurity and poverty in West Africa as the Country marked its 16th Armed ...

Bio-Rad develops products and solutions for the life sciences research and clinical diagnostic markets and enjoys niche market leadership in diagnostic quality controls, antigens, and digital ...

Unity stock has tumbled twice recently, first after Google's Project Genie Reveal, and then after a disappointing earnings report. Project Genie is impressive, but it won't replace video game engines.

Bio-Rad Laboratories Inc. reports fourth-quarter results Thursday after market close, with investors looking to see whether the life sciences tools maker can sustain momentum from a strong prior ...

Edward Chung: Today, we will review the fourth quarter and full year 2025 financial results and provide an update on key business trends for Bio-Rad Laboratories, Inc. With me on the call today are ...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Unity Software (NYSE:U) has integrated Coda directly into its in app purchasing workflow.

Electric bike company Rad Power Bikes has reached a deal to sell itself to a company called Life Electric Vehicles Holdings (or Life EV) for around $13.2 million, a little more than a month after ...

I hope you find this asset as useful as I have to integrate WEB Audio API by Howler.JS to your Unity projects. Unity Engine is a powerful cross-platform game engine, and plugin allows developers to ...

Rad Power Bikes, one of the most well-known electric bicycle companies in North America, appears to be headed for collapse as troubling signs have continued to stack up. The Seattle, Washington-based ...

Rad Power Bikes has informed its employees that it will shut down in January if it is unable to find new funding or get acquired, according to an internal staff email viewed by TechCrunch. The company ...

The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but growth rates were low. Bio-Rad's Q3 saw the company book ...